PAVmed Inc.: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Mar 14, 2023 and accepted by EDGAR at Mar 13, 2023, 22:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $377.0k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-01-01 to 2022-12-31 | $3.6m | us-gaap:CostOfRevenue |
| Research and development | 12 months2022-01-01 to 2022-12-31 | $25.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | −$90.9m | us-gaap:OperatingIncomeLoss |
| Net income | 12 months2022-01-01 to 2022-12-31 | −$89.0m | us-gaap:NetIncomeLoss |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | −$1.00 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | −$71.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $1.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-12-31 | $39.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $43.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $54.0m | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $41.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $43.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-12-31 | −$9.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-23-007481. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.